Using machine learning to better predict recovery after lumbar spine surgery

FHS
June 3, 2024
8:19 pm

Researchers who had been using Fitbit data to help predict surgical outcomes have a new method to more accurately gauge how patients may recover from spine surgery.

Marker to offload cell manufacturing assets to CellReady

Marker’s T cell therapy has shown potential in identifying and killing cancer cells. Credit: NICHD/J. Lippincott-Schwartz / Flickr (Creative Commons). Marker Therapeutics has reached a

May 2, 2023

Grant awarded to build a portable PET scanner for early Alzheimer’s detection

Weill Cornell Medicine researchers have received a five-year $6.2 million grant from the National Institute on Aging, part of the National Institutes of Health, to

November 4, 2024

Cybin to Acquire Small Pharma Inc. | Psychedelic Invest

–All-share transaction creates international clinical-stage leader in novel psychedelic therapeutics – – Two proprietary, advanced clinical programs in development for depression and anxiety disorders with

August 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.